Taysha Gene Therapies, Inc.
TSHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001806310
In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Taysha Gene Therapies, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 71 | 2 | 59 | −10 |
| Shares | 17.0M | 22.5K | 14.7M | −2.29M (−13.5%) |
| Value | $110.9M | $146.0K | $54.7M | −$56.1M (−50.6%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 442,600 | $1.65M | 0.07% |
| Millennium Management LLC | 216,168 | $804.0K | 0.00% |
| Carlson Capital L P | 165,000 | $614.0K | 0.04% |
| Ergoteles LLC | 91,800 | $341.0K | 0.01% |
| Bridgeway Capital Management, LLC | 70,809 | $263.0K | 0.01% |
| Acadian Asset Management LLC | 53,447 | $199.0K | 0.00% |
| Cornercap Investment Counsel Inc | 39,756 | $148.0K | 0.03% |
| Susquehanna International Group, LLP | 21,163 | $79.0K | 0.00% |
| Qube Research & Technologies Ltd | 17,836 | $66.0K | 0.00% |
| HSBC Holdings PLC | 16,570 | $63.0K | 0.00% |
| RBF Capital, LLC | 13,800 | $51.0K | 0.00% |
| AQR Capital Management LLC | 10,134 | $38.0K | 0.00% |
| Allworth Financial LP | 1,000 | $4.00K | 0.00% |
| Truvestments Capital LLC | 380 | $1.00K | 0.00% |
Sold out (24)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 18,928 | $123.0K |
| Amalgamated Financial Corp. | 3,535 | $23.0K |